| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | R. F. Seamark | |
| P2860 | cites work | Genetic transformation of mouse embryos by microinjection of purified DNA | Q24608157 |
| Altering the genome by homologous recombination | Q28270159 | ||
| Human metallothionein genes--primary structure of the metallothionein-II gene and a related processed gene | Q28279126 | ||
| Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells | Q28291434 | ||
| Prenatal lethality in a transgenic mouse line is the result of a chromosomal translocation | Q33553804 | ||
| Targeting of an inducible toxic phenotype in animal cells | Q33654882 | ||
| Specific neuronal expression of human NGF receptors in the basal forebrain and cerebellum of transgenic mice | Q33897519 | ||
| Expression of retroviral vectors in transgenic mice obtained by embryo infection | Q33928812 | ||
| Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice | Q34175241 | ||
| Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes | Q34274059 | ||
| Structure and regulation of the sheep metallothionein-Ia gene | Q36480659 | ||
| Insulin-like growth factors and their binding proteins | Q36583107 | ||
| Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes | Q36592693 | ||
| Developmental regulation of alpha-fetoprotein genes in transgenic mice | Q36903431 | ||
| Multiple regulatory elements in the intergenic region between the alpha-fetoprotein and albumin genes | Q36909561 | ||
| Transgenic animals as bioreactors for pharmacological products. | Q37918072 | ||
| Intracrine regulation at the nucleus--a further mechanism of growth factor activity? | Q37942658 | ||
| Modulation of eukaryotic gene expression by complementary RNA or DNA sequences | Q38212410 | ||
| T-cell tolerance in transgenic mice expressing major histocompatibility class I molecules in defined tissues | Q38606069 | ||
| The new mouse genetics: altering the genome by gene targeting | Q38646807 | ||
| Transgenic mice and oncogenesis | Q39222383 | ||
| Transgenic mice with immunoglobulin genes | Q39595449 | ||
| Germ-line transformation of mice | Q39757195 | ||
| Microinjection of somatic cells with micropipettes: comparison with other transfer techniques | Q40078850 | ||
| Metallothionein-Human GH Fusion Genes Stimulate Growth of Mice | Q40161822 | ||
| Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells | Q41357447 | ||
| Transgenes as probes for active chromosomal domains in mouse development | Q43467878 | ||
| Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice | Q43690324 | ||
| Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma | Q44506225 | ||
| The hypogonadal mouse: reproductive functions restored by gene therapy | Q45887037 | ||
| A dominant phenocopy of hypopituitarism in transgenic mice resulting from central nervous system synthesis of human growth hormone. | Q45934725 | ||
| Dwarf mice produced by genetic ablation of growth hormone-expressing cells | Q48093651 | ||
| A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes | Q48397666 | ||
| SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice | Q48467800 | ||
| Tissue-specific posttranslational processing of pre-prosomatostatin encoded by a metallothionein-somatostatin fusion gene in transgenic mice | Q48494752 | ||
| Stress-induced secretion of human growth hormone in transgenic mice. | Q51617417 | ||
| A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. | Q52241373 | ||
| Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes. | Q52246669 | ||
| Establishment of hamster blastocyst-derived embryonic stem (ES) cells | Q52251811 | ||
| Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. | Q52254920 | ||
| Gene transfer into murine stem cells and mice using retroviral vectors. | Q53547748 | ||
| Pluripotential stem cell lines as a route into the mouse germ line | Q56140130 | ||
| Multiple consequences of human growth hormone expression in transgenic mice | Q57198155 | ||
| Pituitary Mammosomatotroph Adenomas Develop in Old Mice Transgenic for Growth Hormone-Releasing Hormone | Q57795693 | ||
| Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells | Q59058087 | ||
| Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic β cells | Q59073388 | ||
| Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance | Q59080915 | ||
| Growth enhancement of transgenic mice expressing human insulin-like growth factor I | Q67979226 | ||
| Limited transcription of rat elastase I transgene repeats in transgenic mice | Q68310579 | ||
| Expression of Insulin-Like Growth Factor I in Transgenic Mice with Elevated Levels of Growth Hormone Is Correlated with Growth* | Q68411075 | ||
| Mini-mouse: disruption of the pygmy locus in a transgenic insertional mutant | Q68712321 | ||
| Major secretory protein of human decidualized endometrium in pregnancy is an insulin-like growth factor-binding protein | Q69042296 | ||
| Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene | Q69344366 | ||
| Transgenic animals | Q69352129 | ||
| Endogenous human growth hormone (GH) modulates the effect of gonadotropin-releasing hormone on pituitary function and the gonadotropin response to the negative feedback effect of testosterone in adult male transgenic mice bearing human GH gene | Q70412978 | ||
| Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection | Q70912216 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biochemistry | Q7094 |
| endocrinology | Q162606 | ||
| genetically modified animal | Q2850018 | ||
| P304 | page(s) | 833-845 | |
| P577 | publication date | 1991-12-01 | |
| P1433 | published in | Bailliere's clinical endocrinology and metabolism | Q27709241 |
| P1476 | title | The use of transgenic animals to study the role of growth factors in endocrinology | |
| P478 | volume | 5 |
Search more.